• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Imaging and Risks in Desmoid Tumors

Opinion
Video

Experts discuss advancements in imaging techniques and risk factors associated with desmoid tumors, emphasizing the importance of accurate evaluation and management decisions.

This is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild, PharmD, MS, MBA; Tony Phillip, MD; Mrinal Gounder, MD; Ravin Ratan, MD, MEd; and Derek Van Amerongen, MD, MS.

Ratan emphasizes the crucial role of obtaining a tissue diagnosis before intervening or treating desmoid tumors, highlighting the significance of advancements in imaging and biopsy techniques. Phillip underscores that most desmoid cases are sporadic, with only approximately 15% associated with certain mutations such as that of the APC gene, often linked to Gardner syndrome. Gounder cautions against simplifying associations between estrogen-related factors and desmoid tumors, stressing the complexity of cytokines and immune changes in the development of these tumors. The speakers, including Haumschild, discuss risk factors, with Ratan adding that trauma from surgeries may contribute to desmoid development in patients with APC mutations. The conversation emphasizes evolving imaging techniques, risk factor awareness, and the complexity of understanding desmoid tumor causation. Ongoing research, multidisciplinary collaboration, and patient education are key components in navigating the evaluation and management of desmoid tumors effectively.

Video synopsis is AI generated and reviewed by AJMC® editorial staff.

Related Videos
Video 4 - "Oral SERDs in Development for ER+/HER2- Metastatic Breast Cancer"
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
"Integrating New PAH Therapies into Clinical Practice"
"Clinical Evidence for Emerging PAH Therapies"
Video 13 - "Individualized Therapy for Specific Infections Associated with Bronchiectasis"
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Video 15 - "Ensuring Fair Cardiovascular Care for All: Concluding Perspectives on Disparities and Inclusion"
Video 11 - "Social Burden and Goals of Therapy for Patients with Bronchiectasis"
Video 7 - "Harnessing Continuous Glucose Monitors for Type 1 Diabetes Management + Closing Words"
Video 14 - "Achieving Equitable Representation in Clinical Studies"
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.